Action OMND OPTIMIND PHARMA CORP.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Optimind Pharma Corp.

Actions

OMND

CA68405U1012

Marché Fermé - Canadian Securities Exchange
Autres places de cotation
 20:36:34 16/07/2024 		Varia. 5j. Varia. 1 janv.
0,005 CAD 0,00 % Graphique intraday de Optimind Pharma Corp. 0,00 % 0,00 %
29/06 Optimind Pharma Corp. annonce ses résultats pour l'année complète terminée le 29 février 2024 CI
10/01 Optimind Pharma Corp. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 novembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Optimind Pharma Closes First Tranche of Private Placement
Optimind Pharma - Private Placement
Optimind Pharma Corp. announced that it expects to receive CAD 0.5 million in funding
Optimind Pharma Corp. Reports Earnings Results for the Full Year Ended February 29, 2024
Optimind Pharma Reaches Agreement On Debenture Conversion
Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023
Optimind Pharma Corp. Announces Executive Changes
Optimind Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023
Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions
Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended May 31, 2023
Optimind Pharma Corp. Auditor Raises 'Going Concern' Doubt
Optimind Pharma Corp. Reports Earnings Results for the Full Year Ended February 28, 2023
Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy
Optimind Pharma Corp. acquired MindSetting Inc. from Beatrice Society Inc. for CAD 1.6 million.
Optimind Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Optimind Pharma Corp. Provides Update on Health Canada's Dealer License Under Joint-Venture with Manitari Pharma Corporation
Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
Optimind Pharma Inc. completed the acquisition of Loon Energy Corporation (TSXV:LNE.H) in a reverse merger transaction.
Optimind Pharma Corp. announced that it has received CAD 0.507 million in funding
Optimind Pharma Inc. entered into a letter of intent to acquire Loon Energy Corporation (TSXV:LNE.H) for CAD 8.3 million in a reverse merger transaction.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action OMND
  4. Actualités Optimind Pharma Corp.
  5. Autres langues